Skip to main content


Freshfields advises Kartesia on the financing of a share purchase in FormMed Group

Global law firm Freshfields Bruckhaus Deringer (‘Freshfields’) has advised funds managed by Kartesia on an acquisition financing. Kartesia is providing debt financing for the acquisition of shares in FormMed Group by funds managed by Avedon. The seller of the shares is the founder of the group, who significantly re-invested in the firm.

The FormMed Group, based in Frankfurt am Main, is the market leader in physician-assisted micronutrient medicine in Germany. With over 400 preparations, it carries the largest micronutrient medicine concept from Germany. The company only provides products produced in Germany. With the support of the new owner, the company intends to continue its successful growth path and accelerate it further in the medium term through strategic acquisitions.

Kartesia offers flexible debt financing for small and medium-sized enterprises in Europe and has an extensive professional network at its disposal. The diversified product portfolio includes long-term liquidity and credit solutions - e.g. for financing growth, acquisitions and buy-outs as well as recapitalisations. Kartesia's versatile approach allows it to be open to a wide range of transactions, from the acquisition of small individual positions to entire debt portfolios.

The Freshfields team was led by Partner Michael Josenhans and included Principal Associate Christina Banz and Associate Matthis Grenzer (all Financing, Frankfurt) as well as Partner Martin Schiessl, Principal Associate Claus-Peter Knöller and Associate Sebastian Jung (all Tax, Frankfurt).